BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. Pediatr Surg Int. 2009;25:261-267. [PMID: 19184056 DOI: 10.1007/s00383-009-2325-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Homchan K, Chaiwatanarat T, Udomsinprasert W, Chongsrisawat V, Poovorawan Y, Honsawek S. Low bone mineral density and the severity of cholestasis in biliary atresia. World J Hepatol 2017;9:746-51. [PMID: 28652893 DOI: 10.4254/wjh.v9.i16.746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Liu X, Liang Y, Xia N, Liu W, Yang Q, Wang C. Decrease in leptin mediates rat bone metabolism impairments during high-fat diet-induced catch-up growth by modulating the OPG/RANKL balance. 3 Biotech 2021;11:103. [PMID: 33552831 DOI: 10.1007/s13205-021-02658-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu Y, Liu J, Guo H, Luo Q, Yu Z, Liao E, Zu X. Establishment of OPG Transgenic Mice and the Effect of OPG on Bone Microarchitecture. Int J Endocrinol 2013;2013:125932. [PMID: 23606836 DOI: 10.1155/2013/125932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Oostra DR, Lustberg MB, Reinbolt RE, Pan X, Wesolowski R, Shapiro CL. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Mol Cell Endocrinol 2015;402:51-6. [PMID: 25575458 DOI: 10.1016/j.mce.2014.12.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]